BSL — Bhayani Securities (Pvt) Ltd.
OTSU logo

Otsuka Pakistan Limited OTSU

Market closed

Rs 430.00

+19.10 (+4.65%)

Vol10,787Updated15:492 Nov 2026

At a Glance

The headline take on OTSU — valuation, income, returns, and efficiency

Consolidated snapshot

Otsuka Pakistan Limited (OTSU) is a Pharmaceuticals company listed on the Pakistan Stock Exchange. As of 02 Nov 2026, OTSU last traded at Rs 430.00 (+4.65% on the day) with a market cap of Rs 4.97B and a free float of 25.0%. Over the last 12 months the stock has returned +28.2%. The stock trades at a P/E of 10.5x.

Prices through 02 Nov 2026 · FY data through FY26 · Quarterly through Sep-26

10.5x
Rs 39.02
1Y Return
+28.2%
Rs 4.97B

Price & Performance

Closing prices across timeframes, returns, and range context

OTSU — Price History

Daily closing series · toggle period below

1M Return+14.0%
3M Return-0.6%
6M Return+34.8%
1Y Return+28.2%
Day's Range81% of range
Rs 430.00
LowRs 392.00
HighRs 439.00
52-Week Range86% of range
Rs 430.00
LowRs 261.00
HighRs 456.46

Key Metrics

Valuation, profitability, structure, and risk in one grid

10.5xTrailing annual EPS
Rs 39.02Latest annual · basic
7.48xBook Rs 57.52
—No recent payout
0.82Lower than market
Rs 4.97BSmall cap
25.0%3.02M shares
155.75High leverage
4.1%Latest annual
Rs 10Per share

Dividend History & Yield

Payout track record, yield trend, and upcoming distribution

Latest Payout

Per Share
—
Yield (last FY)
—
Payout Ratio
—
Announced
—

Dividend Per Share Trend

2021
Rs 1.50
2022
Rs 1.50
2023
Rs 1.50
2024
Rs 0.00
2025
Rs 0.00

Financials & Earnings

Income, balance sheet, and key ratios from published accounts

OTSU's market capitalisation stands at Rs 4.97B as of 30 Oct 2026 — up 29.2% over the past 12 months (from Rs 3.85B).

Financial Statements

How OTSU's income and balance sheet have evolved

PKR MillionsFY26FY25FY24FY23FY22FY21Trend
Net Sales / Revenue4,111.113,779.523,1643,0352,8522,546
Cost of Sales2,652.22,916.122,5872,3911,9251,701
Gross Profit1,458.9863.4577644927845
Administrative Expenses220.56195.14148127142108
Operating Profit782.97162.9159157437459
EBITDA—243148256537556
Other Income291.67128.2918710261107
Financial Charges11.25.910364719
Profit Before Tax771.7715719-28365470
Taxation299.64129.33242113383
Profit After Tax472.1327.68-5-7232386
EPS - Basic (Rs)Rs 39.02Rs 2.29Rs -0.39Rs -0.60Rs 19.16Rs 31.93

All figures in PKR millions from published accounts.

Profitability & Returns

Margins, returns on capital, and earnings per share

Latest · FY25

RatioValue
Net profit margin0.7%
Gross profit margin22.8%
EBITDA margin6.4%
EBIT margin4.3%

Net profit margin

Net profit ÷ revenue · %

0.0%3.8%7.6%11.4%15.2%15.2%FY218.1%FY22-0.2%FY23-0.2%FY240.7%FY25Period
Earlier periodsLatest period

Financial Health

Coverage, leverage, and the strength of the balance sheet

Latest · FY26

RatioValue
Current ratio1.23
Quick ratio0.39
Cash ratio0.30
Asset turnover1.36x
Effective tax rate38.8%

Current ratio

Current assets ÷ current liabilities

0.000.310.620.921.230.99FY251.23FY26Period
Earlier periodsLatest period

Market cap trajectory

Close × current shares outstanding · current Rs 4.97B

Rs 5.25BRs 3.70BRs 2.14BRs 591.46MOct 25Dec 25Feb 26Apr 26Jul 26Sep 26Rs 4.97B

Valuation & Capital Returns

What the market is paying for OTSU, and what it returns to shareholders

Latest · FY26

RatioValue
Price to earnings10.53x
Price to book4.28x
Price to sales1.21x

Price to earnings

Period-end price ÷ EPS · times

0.00x36.93x73.86x110.78x147.71x147.71xFY2510.53xFY26Period
Earlier periodsLatest period

Technical Analysis

Trading signal, moving averages, momentum, and key levels

Trading Signal
BUY

10-day SMA (Rs 380.54) is above the 30-day SMA (Rs 365.97). RSI at 68 sits in the neutral band.

As of30 Oct 2026

PeriodValuevs CurrentPosition
SMA 10Rs 380.54-11.50%Above
SMA 30Rs 365.97-14.89%Above
SMA 60Rs 377.85-12.13%Above
SMA 200Rs 353.97-17.68%Above
68Neutral
0 · Oversold305070100 · Overbought

At 68, momentum sits within the neutral band (30–70), suggesting balanced buying and selling pressure.

MACD
Bullish Cross
  • MACD7.65
  • Signal2.81
  • Histogram+4.83
R2Resistance 2
Rs 490.30
14.0%
R1Resistance 1
Rs 450.60
4.8%
NOWCurrent
Rs 430.00
S1Support 1
Rs 359.60
-16.4%
S2Support 2
Rs 308.30
-28.3%

Leverage Insights

MTS, margin financing, futures open interest, and combined exposure

—Not MTS-eligible
Rs 1.91M
Margin financing
Rs 1.91M
-16.49% MoMMTS + MFS combined

Leverage Composition

MTS · MFS stacked over the selected window

No blank sales

No net blank (short) sales reported for OTSU on the latest PSX DFC report.

Settlement Insights

UIN-wise settlement concentration and price context

Metrics and charts over the selected trailing window

Latest UIN %80.82%Most recent print
Average · 3M88.64%Mean over window
Change · 3M-17.22%First → last
Range · 3M40.5–100.0%Low–high

Settlement % Trajectory

Solid = UIN settlement % · Dashed = 14-session EMA

As of 30 Oct 2026

Price vs Settlement

Close price (left axis) · UIN settlement % (right axis)

Share Structure & Capital

Float composition, capital base, and enterprise value

Free float · 25.0%Non-float · 75.0%

Free float vs locked-in holdings

Paid-Up CapitalRs 121.00M
Total Shares12.10M
3.02M
25.0%
Year EndJun
Enterprise Value—

About the Company

Business description, governance, and corporate information

Otsuka Pakistan Limited was incorporated in Pakistan as a public limited company. The Company is engaged in the manufacturing, marketing, and distribution of intravenous infusions and trading in pharmaceutical products, nutritional foods, and medical equipment. The company is an indirect subsidiary of Otsuka Pharmaceutical Company Limited, Japan

Shariah CompliantPharmaceuticals

Corporate Information

  • RegistrarTHK Associates (Private) Limited, Plot No. 32-C, Jami Commercial Street 2, D.H.A, Phase-VII, Karachi
  • AuditorM/s. Yousuf Adil Chartered Accountants
  • Websitewww.otsuka.pk
  • Address30 - B, Sindhi Muslim Co-Operative, Housing Society, Karachi
  • SectorPharmaceuticals
  • Financial Year EndJune

Key People

NameRole
MUMoin Ur Rehman
CEO
MBMikio Bando
Chairperson
SKShahab Khalid Subzwari
Company Secretary

Recent Announcements

Latest company filings as reported on PSX

Peers in Pharmaceuticals

How the cohort is moving — same-sector stocks by market cap

OTSU vs Pharmaceuticals sector median

Median across 15 sector constituents · nulls excluded per metric

MetricOTSUSector median
10.5x12.7x
0.0%2.7%
4.1%16.9%
1-Year Return+28.2%-20.1%
Rs 4.97BRs 15.17B

Why Choose BSL as Your PSX Broker?

Bhayani Securities is an SECP-licensed stock broker in Pakistan and PSX TREC holder with over two decades in the market. Investors get live prices, research and support in one account.

  • Retail Trading

    Open a PSX trading account with secure market access and research support.

  • Online Trading

    Trade on the BSL app with real-time PSX data and portfolio monitoring.

  • Margin Financing

    Borrow to trade larger positions and increase your buying power.

  • Research Reports

    Market insights, stock analysis and investing guides from BSL.

  • Institutional Services

    Research-driven execution, market insights and corporate access for institutions.

  • High Net Worth Services

    A dedicated senior dealer and preferential rates for portfolios above PKR 2.5 million.

  • Trading APIs

    Full PSX data, live level-2 market data and sandbox order execution through BSL.

  • Roshan Digital Account

    Invest in the PSX remotely as an overseas Pakistani.

  • Sahulat Account

    Start investing with minimal documentation and a fast setup.

  • Minor Accounts

    Invest for your children and build long-term wealth early.

Frequently Asked Questions

The most common questions investors ask about OTSU

OTSU last traded at Rs 430.00, up 4.65% on the day, within a 52-week range of Rs 261.00–456.46. Prices on this page refresh every 15 minutes during market hours; log in to BSL for live quotes.

Ready to invest in OTSU?

Open a BSL trading account in under 10 minutes

Buy and sell OTSU and every other PSX-listed stock with low commissions, real-time data, and a concierge research desk backing every trade.